Exploring the Prognostic Value of Tumour‐Associated Genes in Clear Cell Renal Cell Carcinoma Through Single‐Cell RNA Sequencing Insights
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Tongfei Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Single-Cell Analysis, Kidney Neoplasms, Tumor Microenvironment. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC) characterised by its diversity and a tendency to defy standard therapeutic approaches. Amidst the advent of immunotherapy, it has become imperative to pinpoint prognostic indicators of the tumour microenvironment (TME) influence the efficacy of treatments. Employing single‐cell RNA sequencing (scRNA‐seq), this research delved into the diverse landscape of ccRCC, uncovering its complex underpinnings and pinpointing molecular avenues for therapeutic intervention. We constructed a prognostic model using 101 machine learning algorithms and integrated data from multiple cohorts, including TCGA, ICGC, and microarray datasets. The model's efficacy was assessed using the Concordance Index (C‐index), and further analyses included pseudotime analysis of tumour cells, mutation analysis and correlation analysis between the prognostic model and tumour immunity. The prognostic model, combining Lasso regression and survival Support Vector Machine (SVM), demonstrated robust discrimination with a C‐index of 0.650. Investigation into the TME uncovered pronounced associations between the presence of immune cell infiltrates and patient outcomes, with a notable emphasis on the impact of CCL2‐expressing neoplastic cells. The GO Biological Processes (GOBP) encompass the regulation of endothelial cell maturation, the formation of endothelial layers, the enhancement of gene expression controlled by Notch receptors, and the development of endothelial barriers. The research effectively pinpointed critical prognostic markers and crafted a forecasting model that achieved a C‐index of 0.650, highlighting the significant impact of immune cell infiltration, especially CCL2+ neoplastic cells, on ccRCC patient prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- The First Clinical College, Hubei University of Chinese Medicine, Wuhan, China.
- Department of Anorectal, The Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, ShenYang, China.
- The Third Clinical Department, Liaoning University of Traditional Chinese Medicine, ShenYang, China.
- College of Clinical Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
- Department of Critical Care Medicine, Yichang Hospital of Traditional Chinese Medicine, Yichang, China.
ORCID-Profile: Yongli Zhan
Zitieren
APA
Fu, T., Zhang, X., Liu, Y., Wu, J., Liu, X., Lu, B., Huang, Y., Yang, L., & Zhan, Y. (2024). Exploring the Prognostic Value of Tumour‐Associated Genes in Clear Cell Renal Cell Carcinoma Through Single‐Cell RNA Sequencing Insights. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70297
Vancouver
Fu T, Zhang X, Liu Y, Wu J, Liu X, Lu B, et al. Exploring the Prognostic Value of Tumour‐Associated Genes in Clear Cell Renal Cell Carcinoma Through Single‐Cell RNA Sequencing Insights. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70297
BibTeX
@article{Fu2024,
author = {Fu, Tongfei and Zhang, Xinyi and Liu, Yuedong and Wu, Junsong and Liu, Xuefeng and Lu, Bichao and Huang, Yi and Yang, Liping and Zhan, Yongli},
title = {Exploring the Prognostic Value of Tumour‐Associated Genes in Clear Cell Renal Cell Carcinoma Through Single‐Cell RNA Sequencing Insights},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70297}
}
EUVIMED